SEC Form 4 · accession 0001209191-17-065251
Denali Therapeutics Inc. · DNLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Keith Crandell
10% Owner
Clinton Bybee
10% Owner
ARCH Venture Fund VIII, L.P.
10% Owner
ARCH Venture Partners VIII, LLC
10% Owner
ARCH Venture Partners VIII, L.P.
10% Owner
Period of report
Dec 12, 2017
Accepted (ET)
Dec 12, 2017 · 5:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001714899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3,F4 | Dec 12, 2017 | C | 10,756,249 | — | A | 11,068,749 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A-1 Preferred StockF4,F1 | — | Dec 12, 2017 | C | 10,068,749 | D | — | — | Common Stock | 10,068,749 | 0 | D |
| Series A-2 Preferred StockF4,F2 | — | Dec 12, 2017 | C | 375,000 | D | — | — | Common Stock | 375,000 | 0 | D |
| Series B-1 Preferred StockF4,F3 | — | Dec 12, 2017 | C | 312,500 | D | — | — | Common Stock | 312,500 | 0 | D |
Explanation of responses
- F1The Series A-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- F2The Series A-2 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- F3The Series B-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- F4The shares are directly held by ARCH Venture Fund VIII, L.P. ("ARCH VIII"). ARCH Venture Partners VIII, L.P. (the "GPLP"), as the sole general partner of ARCH VIII, may be deemed to beneficially own certain of the shares held by ARCH VIII. ARCH Venture Partners VIII, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH VIII. The GPLP and GPLLC disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein. Keith Crandell and Clinton Bybee, as managing directors of GPLLC, may be deemed to beneficially own the shares held by ARCH VIII. Messrs. Crandell and Bybee disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein.